Literature DB >> 21244368

Regulation of renal sympathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.

Henning Hoch1, Johannes Stegbauer, Sebastian A Potthoff, Lutz Hein, Ivo Quack, Lars Christian Rump, Oliver Vonend.   

Abstract

BACKGROUND AND
PURPOSE: The mechanisms underlying increased renal noradrenaline in renal failure are still unclear. In this study, the role of α(2A)-adrenoceptors in controlling sympathetic neurotransmission in chronic renal failure was evaluated in a subtotal nephrectomy model. Also, the influence of this receptor subtype on angiotensin II (Ang II)-mediated noradrenaline release was evaluated. EXPERIMENTAL APPROACH: α(2A)-adrenoceptor-knockout (KO) and wild-type (WT) mice underwent subtotal (5/6) nephrectomy (SNx) or SHAM-operation (SHAM). Kidneys of WT and KO mice were isolated and perfused. Renal nerves were stimulated with platinum electrodes and noradrenaline release was measured by HPLC. KEY
RESULTS: Noradrenaline release induced by renal nerve stimulation (RNS) was significantly increased in WT mice after SNx. RNS-induced noradrenaline release was significantly higher in SHAM-KO compared with SHAM-WT, but no further increase in noradrenaline release could be observed in SNx-KO. α-adrenoceptor antagonists increased RNS-induced noradrenaline release in SHAM-WT but not in SHAM-KO. After SNx, the effect of α₂-adrenoceptor blockade on renal noradrenaline release was attenuated in WT mice. The mRNA expression of α(2A)-adrenoceptors was not altered, but the inhibitory effect of α₂-adrenoceptor agonists on cAMP formation was abolished after SNx. Ang II facilitated RNS-induced noradrenaline release in SHAM-WT but not in SHAM-KO and SNx-WT. CONCLUSION AND IMPLICATIONS: In our model of renal failure autoregulation of renal sympathetic neurotransmission was impaired. Presynaptic inhibition of noradrenaline release was diminished and the facilitatory effect of presynaptic angiotensin AT₁ receptors on noradrenaline release was markedly decreased in renal failure and depended on functioning α(2A)-adrenoceptors.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244368      PMCID: PMC3087143          DOI: 10.1111/j.1476-5381.2011.01223.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

Review 1.  Alterations of arterial function in end-stage renal disease.

Authors:  G M London
Journal:  Nephron       Date:  2000-02       Impact factor: 2.847

Review 2.  Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans.

Authors:  Claudio Sartori; Mattia Lepori; Urs Scherrer
Journal:  Pharmacol Ther       Date:  2005-01-12       Impact factor: 12.310

3.  Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney.

Authors:  Oliver Vonend; Johannes Stegbauer; Johann Sojka; Sina Habbel; Ivo Quack; Bernard Robaye; Jean-Marie Boeynaems; Lars Christian Rump
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

4.  Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.

Authors:  L Hein; J D Altman; B K Kobilka
Journal:  Nature       Date:  1999-11-11       Impact factor: 49.962

5.  Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice.

Authors:  Johannes Stegbauer; Oliver Vonend; Sina Habbel; Ivo Quack; Lorenz Sellin; Volkmar Gross; Lars Christian Rump
Journal:  J Hypertens       Date:  2005-09       Impact factor: 4.844

Review 6.  International Union of Pharmacology nomenclature of adrenoceptors.

Authors:  D B Bylund; D C Eikenberg; J P Hieble; S Z Langer; R J Lefkowitz; K P Minneman; P B Molinoff; R R Ruffolo; U Trendelenburg
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

7.  Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension.

Authors:  Shaohua Ye; Huiquin Zhong; Swati Yanamadala; Vito M Campese
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

8.  Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.

Authors:  J D Altman; A U Trendelenburg; L MacMillan; D Bernstein; L Limbird; K Starke; B K Kobilka; L Hein
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

9.  Impaired autofeedback regulation of hypothalamic norepinephrine release in experimental uremia.

Authors:  Katrin Klein; Markus Daschner; Marcel Vogel; Jun Oh; Thomas J Feuerstein; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2005-04-13       Impact factor: 10.121

10.  Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.

Authors:  Ralf Gilsbach; Johanna Schneider; Achim Lother; Stefanie Schickinger; Jost Leemhuis; Lutz Hein
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

View more
  4 in total

1.  Establishment of a rat autogenous arteriovenous fistula model following 5/6 nephrectomy.

Authors:  Chenfei Zheng; Ying Zhou; Chaoxing Huang; Zhouchang Zhang; Y I Liu; Yulan Xu
Journal:  Exp Ther Med       Date:  2015-04-24       Impact factor: 2.447

2.  α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.

Authors:  Lydia Hering; Masudur Rahman; Henning Hoch; Lajos Markó; Guang Yang; Annika Reil; Mina Yakoub; Vikram Gupta; Sebastian A Potthoff; Oliver Vonend; Donna L Ralph; Susan B Gurley; Alicia A McDonough; Lars C Rump; Johannes Stegbauer
Journal:  J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 10.121

Review 3.  Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Authors:  M Archer; N Dogra; Z Dovey; T Ganta; H-S Jang; J A Khusid; A Lantz; M Mihalopoulos; J A Stockert; A Zahalka; L Björnebo; S Gaglani; M R Noh; S A Kaplan; R Mehrazin; K K Badani; P Wiklund; K Tsao; D J Lundon; N Mohamed; F Lucien; B Padanilam; M Gupta; A K Tewari; N Kyprianou
Journal:  Cell Commun Signal       Date:  2021-07-20       Impact factor: 5.712

4.  P2Y2 receptor deficiency aggravates chronic kidney disease progression.

Authors:  Sebastian A Potthoff; Johannes Stegbauer; Jan Becker; P Johannes Wagenhaeuser; Blanka Duvnjak; Lars C Rump; Oliver Vonend
Journal:  Front Physiol       Date:  2013-09-19       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.